Anna Aliberti

Dr. Anna Aliberti

Optoelectronics Group, Department of Engineering, University of Sannio, I-82100 Benevento, Italy

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2023 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
TCTania Mariastella Caputo
Tania Mariastella Caputo
Andrea CusanoAndrea Cusano
Andrea Cusano
SPSofia Principe
Sofia Principe
PCPaola Cicatiello
Paola Cicatiello
GCGiorgia Celetti
Giorgia Celetti
ACAndrea Cusano
Andrea Cusano
Introduction: Currently, conventional treatments of hepatocellular carcinoma (HCC) are not selective enough for tumor tissue and lead to multidrug resistance and drug toxicity. Although sorafenib (SOR) is the standard first-line systemic therapy approved for the clinical treatment of HCC, its poor aqueous solubility and rapid clearance result in low absorption efficiency and severely limit its use for local treatment. Methods: Herein, we present the synthesis of biodegradable polymeric Poly (D, L-Lactide-co-glycolide) (PLGA) particles loaded with SOR (PS) by emulsion-solvent evaporation process. The particles are carefully characterized focusing on particle size, surface charge, morphology, drug loading content, encapsulation efficiency, in vitro stability, drug release behaviour and tested on HepG2 cells. Additionally, PLGA particles have been coupled on side emitting optical fibers (seOF) integrated in a microfluidic device for light-triggered local release. Results: PS have a size of 248 nm, tunable surface charge and a uniform and spherical shape without aggregation. PS shows encapsulation efficiency of 89.7% and the highest drug loading (8.9%) between the SOR-loaded PLGA formulations. Treating HepG2 cells with PS containing SOR at 7.5 μM their viability is dampened to 40%, 30% and 17% after 48, 129 and 168 hours of incubation, respectively. Conclusion: The high PS stability, their sustained release profile and the rapid cellular uptake corroborate the enhanced cytotoxicity effect on HepG2. With the prospect of developing biomedical tools to control the spatial and temporal release of drugs, we successfully demonstrated the potentiality of seOF for light-triggered local release of the carriers. Our prototypical system paves the way to new devices integrating microfluidics, optical fibers, and advanced carriers capable to deliver minimally invasive locoregional cancer treatments. Graphical Abstract:

28 September 2018 in Fibers
Verified
Journal Article
Open access
PDF file
LSLorenzo Scherino
Lorenzo Scherino
MGMartino Giaquinto
Martino Giaquinto
AMAlberto Micco
Alberto Micco
AAAnna Aliberti
Anna Aliberti
EBEugenia Bobeico
Eugenia Bobeico
Andrea CusanoAndrea Cusano
Andrea Cusano
The combination of responsive microgels and Lab-on-Fiber devices represents a valuable technological tool for developing advanced optrodes, especially useful for biomedical applications. Recently, we have reported on a fabrication method, based on the dip coating technique, for creating a microgels monolayer in a controlled fashion onto the fiber tip. In the wake of these results, with a view towards industrial applications, here we carefully analyze, by means of both morphological and optical characterizations, the effect of each fabrication step (fiber dipping, rinsing, and drying) on the microgels film properties. Interestingly, we demonstrate that it is possible to significantly reduce the duration (from 960 min to 31 min) and the complexity of the fabrication procedure, without compromising the quality of the microgels film at all. Repeatability studies are carried out to confirm the validity of the optimized deposition procedure. Moreover, the new procedure is successfully applied to different kinds of substrates (patterned gold and bare optical fiber glass), demonstrating the generality of our findings. Overall, the results presented in this work offer the possibility to improve of a factor ~30 the fabrication throughput of microgels-assisted optical fiber probes, thus enabling their possible exploitation in industrial applications.

6 April 2018 in Sensors
Verified
Journal Article
Open access
PDF file
MGMartino Giaquinto
Martino Giaquinto
AMAlberto Micco
Alberto Micco
AAAnna Aliberti
Anna Aliberti
EBEugenia Bobeico
Eugenia Bobeico
Vera La FerraraVera La Ferrara
Vera La Ferrara
Andrea CusanoAndrea Cusano
Andrea Cusano
Integrating multi-responsive polymers such as microgels onto optical fiber tips, in a controlled fashion, enables unprecedented functionalities to Lab-on-fiber optrodes. The creation of a uniform microgel monolayer with a specific coverage factor is crucial for enhancing the probes responsivity to a pre-defined target parameter. Here we report a reliable fabrication strategy, based on the dip coating technique, for the controlled realization of microgel monolayer onto unconventional substrates, such as the optical fiber tip. The latter was previously covered by a plasmonic nanostructure to make it sensitive to superficial environment changes. Microgels have been prepared using specific Poly(N-isopropylacrylamide)-based monomers that enable bulky size changes in response to both temperature and pH variations. The formation of the microgel monolayer is efficiently controlled through the selection of suitable operating pH, temperature and concentration of particle dispersions used during the dipping procedure. The effect of each parameter has been evaluated, and the validity of our procedure is confirmed by means of both morphological and optical characterizations. We demonstrate that when the coverage factor exceeds 90%, the probe responsivity to microgels swelling/collapsing is significantly improved. Our study opens new paradigms for the development of engineered microgels assisted Lab-on-Fiber probes for biochemical applications.

1 November 2023 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
TCTania Mariastella Caputo
Tania Mariastella Caputo
GBGiovannina Barisciano
Giovannina Barisciano
CMChiara Mulè
Chiara Mulè
Andrea CusanoAndrea Cusano
Andrea Cusano
AAAnna Aliberti
Anna Aliberti
ACAndrea Cusano
Andrea Cusano
Background: Trastuzumab, a therapeutic monoclonal antibody directed against HER2, is routinely used to treat HER2-positive breast cancer with a good response rate. However, concerns have arisen in the clinical practice due to adverse side effects. One way to overcome these limitations is to encapsulate trastuzumab in nanoparticles to improve cytotoxic activity, increase intracellular drug concentrations, escape the immune system and avoid systemic degradation of the drug in vivo. Methods: A double emulsion method was used to encapsulate trastuzumab into poly(lactic-co-glycolic) nanoparticles, effective for their biocompatibility and biodegradability. These nanocarriers, hereafter referred to as TZPs, were characterised in terms of size, homogeneity, zeta potential and tested for their stability and drug release kinetics. Finally, the TZPs cytotoxicity was assessed in vitro on the HER2 positive SKBR3 breast cancer cell line and compared to free trastuzumab. Results: The TZPs were stable, homogeneous in size, with a reduced zeta potential. They showed higher encapsulation efficiency and drug loading, a prolonged trastuzumab release kinetics that retained its physicochemical properties and functionality. TZPs showed a stronger cytotoxicity and increased apoptosis than similar doses of free trastuzumab in the cell line analysed. Confocal microscopy and flow cytometry assessed TZPs and trastuzumab cellular uptake while Western blot evaluated downstream signalling, overall HER2 content and shedding. Conclusion: TZPs exert more robust effects than free trastuzumab via a dual mode of action: TZPs are taken up by cells through an endocytosis mechanism and release the drug intracellularly for longer time. Additionally, the TZPs that remain in the extracellular space release trastuzumab which binds to the cognate receptor and impairs downstream signalling. This is the sole modality used by free trastuzumab. Remarkably, half dose of TZPs is as efficacious as the highest dose of free drug supporting their possible use for drug delivery in vivo.

22 December 2015 in The Analyst
Verified
Journal Article
Closed access
PDF file
AAAnna Aliberti
Anna Aliberti
Andrea CusanoAndrea Cusano
Andrea Cusano
EBEdmondo Battista
Edmondo Battista
Filippo CausaFilippo Causa
Filippo Causa
PNPaolo Netti
Paolo Netti
A novel class of probes for fluorescence detection was developed and combined to microgel particles for a high sensitive fluorescence detection of nucleic acids. A double strand probe with an optimized fluorescent–quencher couple was designed for the detection of different lengths of nucleic acids (39 nt and 100 nt). Such probe proved efficient in target detection in different contests and specific even in presence of serum proteins. The conjugation of double strand probes onto polymeric microgels allows for a sensitive detection of DNA sequences from HIV, HCV and SARS corona viruses with a LOD of 1.4 fM, 3.7 fM and 1.4 fM, respectively, and with a dynamic range of 10−9–10−15 M. Such combination enhances the sensitivity of the detection of almost five orders of magnitude when compared to the only probe. The proposed platform based on the integration of innovative double strand probe into microgels particles represents an attractive alternative to conventional sensitive DNA detection technologies that rely on amplifications methods.

21 April 2022 in Biosensors
Verified
Journal Article
Open access
PDF file
HAHiba AlHalaby
Hiba AlHalaby
Maria PrincipeMaria Principe
Maria Principe
HZHaitham Zaraket
Haitham Zaraket
Patrizio VaianoPatrizio Vaiano
Patrizio Vaiano
AAAnna Aliberti
Anna Aliberti
Andrea CusanoAndrea Cusano
Andrea Cusano
The need for miniaturized biological sensors which can be easily integrated into medical needles and catheters for in vivo liquid biopsies with ever-increasing performances has stimulated the interest of researchers in lab-on-fiber (LOF) technology. LOF devices arise from the integration of functional materials at the nanoscale on the tip of optical fibers, thus endowing a simple optical fiber with advanced functionalities and enabling the realization of high-performance LOF biological sensors. Consequently, in 2017, we demonstrated the first optical fiber meta-tip (OFMT), consisting of the integration of plasmonic metasurfaces (MSs) on the optical fiber end-face which represented a major breakthrough along the LOF technology roadmap. Successively, we demonstrated that label-free biological sensors based on the plasmonic OFMT are able to largely overwhelm the performance of a standard plasmonic LOF sensor, in view of the extraordinary light manipulation capabilities of plasmonic array exploiting phase gradients. To further improve the overall sensitivity, a labelled sensing strategy is here suggested. To this end, we envision the possibility to realize a novel class of labelled LOF optrodes based on OFMT, where an all-dielectric MS, designed to enhance the fluorescence emission by a labelled target molecule, is integrated on the end-face of a multimode fiber (MMF). We present a numerical environment to compute the fluorescence enhancement factor collected by the MMF, when on its tip a Silicon MS is laid, consisting of an array of cylindrical nanoantennas, or of dimers or trimers of cylindrical nanoantennas. According to the numerical results, a suitable design of the dielectric MS allows for a fluorescence enhancement up to three orders of magnitudes. Moreover, a feasibility study is carried out to verify the possibility to fabricate the designed MSs on the termination of multimode optical fibers using electron beam lithography followed by reactive ion etching. Finally, we analyze a real application scenario in the field of biosensing and evaluate the degradation in the fluorescence enhancement performances, taking into account the experimental conditions. The present work, thus, provides the main guidelines for the design and development of advanced LOF devices based on the fluorescence enhancement for labelled biosensing applications.